IP And Trademarks 3 October 2026
NIT Rourkela Secures Patent for Oral Cancer Therapy
Researchers at NIT Rourkela have secured an Indian patent for a novel cotarnine derivative aimed at oral cancer treatment. The compound, designed and synthesised in-house, shows promising therapeutic potential and could pave the way for new drug development in India.
Patent Granted: NIT Rourkela scientists have obtained an Indian patent for a cotarnineābased compound targeting oral cancer.
- The derivative was designed, synthesised, and evaluated ināhouse.
- Early studies indicate strong therapeutic potential for oral cancer patients.
- Patent filing aims to accelerate development and commercialisation in India.
Read the full report here.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.